Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Cemindo Gemilang Tbk. (CMNT) vs UBC Medical Indonesia Tbk. (LABS) Price & Performance

Cemindo Gemilang Tbk.Trade
UBC Medical Indonesia Tbk.Trade

Price performance (Past 24H)

Key statistics

Cemindo Gemilang Tbk. vs UBC Medical Indonesia Tbk. — how do they compare? Cemindo Gemilang Tbk. trades at Rp790 (market cap 13.53T, 2.26M 24h volume), while UBC Medical Indonesia Tbk. trades at Rp147 (market cap 576.7B, 3.07M 24h volume). The key difference: Cemindo Gemilang Tbk. is far larger — about 23.5× UBC Medical Indonesia Tbk.'s market cap, and UBC Medical Indonesia Tbk. is more actively traded (3.07M versus 2.26M). Which is the better fit depends on your goals.

CMNTLABS
Market Cap
13.53T576.7B
Volume
2.26M3.07M
Lot
22.55K30.65K
Turnover
1.78B461.29M
Average Price
790150.5
Value
1.78B461.29M
Indicative Equilibrium Price
790147
Indicative Equilibrium Volume
700311

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

CMNT
View details
LABS
View details

About Cemindo Gemilang Tbk.

PT Cemindo Gemilang Tbk (the “Company”) was established in Indonesia based on Notarial Deed No. 9 of Humberg Lie, S.H., S.E., M.Kn, dated July 4, 2011.

Read more on CMNT

About UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Read more on LABS